Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
Notwendige Cookies
Diese Cookies sind für das Funktionieren des Logins und die Speicherung der Cookie-Einstellungen erforderlich und können deshalb nicht deaktiviert werden.
CNBC (Consumer News and Business Channel) ist ein amerikanischer Wirtschafts- und Finanznachrichtensender mit weltweiten Vertretungen. Das gesamte Programm ist in seperaten Videos unter cnbc.com verfügbar.
European stocks are expected to start the new trading week in negative territory as the war in Iran showed no signs of ending soon as it entered its fifth week....
U.S. President Donald Trump said Sunday he had "no problem" with any country sending in crude as a Russian tanker neared a Cuban port in an apparent reversal....
Oil prices climbed on Monday after Yemen's Houthis said they had fired missiles at Israel, opening a new front in the U.S.- and Israeli-led conflict with Iran....
Companies are expanding employee benefits to cover a wide variety of caregiving needs, including back-up care for children, aging parents, and pets....
President Trump's plan to ban big investors from home ownership may not be the key to reviving the American Dream in affordable housing legislation....
Parents today try to raise their children for good grades and high achievement. But that's not what we should be focusing on, says child psychologist Reem Raouda, who has studied over 200 kids. She shares the most important skill parents are forgetting to teach today....
President Donald Trump has said this will be the "largest tax refund season of all time," as a result of his "big beautiful bill." Here's what the megabill means for taxpayers....
U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market....
This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, according to a Deutsche Bank analyst....